175 related articles for article (PubMed ID: 15161438)
1. Molecular therapeutic approaches to acute myeloid leukemia: targeting aberrant chromatin dynamics and signal transduction.
Piazza F; Semenzato G
Expert Rev Anticancer Ther; 2004 Jun; 4(3):387-400. PubMed ID: 15161438
[TBL] [Abstract][Full Text] [Related]
2. Acute myeloid leukemia: therapeutic impact of epigenetic drugs.
Altucci L; Clarke N; Nebbioso A; Scognamiglio A; Gronemeyer H
Int J Biochem Cell Biol; 2005 Sep; 37(9):1752-62. PubMed ID: 15964234
[TBL] [Abstract][Full Text] [Related]
3. Novel agents in acute myeloid leukemia.
Aribi A; Ravandi F; Giles F
Cancer J; 2006; 12(2):77-91. PubMed ID: 16630396
[TBL] [Abstract][Full Text] [Related]
4. Targeting receptor tyrosine kinase signaling in acute myeloid leukemia.
Doepfner KT; Boller D; Arcaro A
Crit Rev Oncol Hematol; 2007 Sep; 63(3):215-30. PubMed ID: 17658267
[TBL] [Abstract][Full Text] [Related]
5. [Molecular diagnosis of and molecular targeting therapy for leukemia].
Tabe Y
Rinsho Byori; 2009 Feb; 57(2):137-45. PubMed ID: 19317219
[TBL] [Abstract][Full Text] [Related]
6. New agents in the treatment of acute myeloid leukemia: a snapshot of signal transduction modulation.
Bao T; Smith BD; Karp JE
Clin Adv Hematol Oncol; 2005 Apr; 3(4):287-96, 302. PubMed ID: 16167001
[TBL] [Abstract][Full Text] [Related]
7. Molecular targets and the treatment of myeloid leukemia.
Ikeda A; Shankar DB; Watanabe M; Tamanoi F; Moore TB; Sakamoto KM
Mol Genet Metab; 2006 Jul; 88(3):216-24. PubMed ID: 16678459
[TBL] [Abstract][Full Text] [Related]
8. Signal transduction therapy in haematological malignancies: identification and targeting of tyrosine kinases.
Chase A; Cross NC
Clin Sci (Lond); 2006 Oct; 111(4):233-49. PubMed ID: 16961463
[TBL] [Abstract][Full Text] [Related]
9. Farnesyltransferase inhibitors (FTIs) in myeloid malignancies.
Karp JE; Lancet JE
Ann Hematol; 2004; 83 Suppl 1():S87-8. PubMed ID: 15124688
[TBL] [Abstract][Full Text] [Related]
10. New agents for the treatment of acute myeloid leukemia.
Tallman MS
Best Pract Res Clin Haematol; 2006; 19(2):311-20. PubMed ID: 16516128
[TBL] [Abstract][Full Text] [Related]
11. Combined inhibition of integrin linked kinase and FMS-like tyrosine kinase 3 is cytotoxic to acute myeloid leukemia progenitor cells.
Muranyi AL; Dedhar S; Hogge DE
Exp Hematol; 2009 Apr; 37(4):450-60. PubMed ID: 19302919
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid receptors, hematopoiesis and leukemogenesis.
Collins SJ
Curr Opin Hematol; 2008 Jul; 15(4):346-51. PubMed ID: 18536573
[TBL] [Abstract][Full Text] [Related]
13. Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia.
Cimino G; Lo-Coco F; Fenu S; Travaglini L; Finolezzi E; Mancini M; Nanni M; Careddu A; Fazi F; Padula F; Fiorini R; Spiriti MA; Petti MC; Venditti A; Amadori S; Mandelli F; Pelicci PG; Nervi C
Cancer Res; 2006 Sep; 66(17):8903-11. PubMed ID: 16951208
[TBL] [Abstract][Full Text] [Related]
14. Molecularly targeted therapy in acute myeloid leukemia.
Bernasconi P; Boni M; Cavigliano PM; Calatroni S; Giardini I; Rocca B; Zappatore R; Caresana M; Quarna J
Ann N Y Acad Sci; 2004 Dec; 1028():409-22. PubMed ID: 15650266
[TBL] [Abstract][Full Text] [Related]
15. FLT3 inhibition in acute myeloid leukaemia.
Knapper S
Br J Haematol; 2007 Sep; 138(6):687-99. PubMed ID: 17655729
[TBL] [Abstract][Full Text] [Related]
16. Mutant transcription factors and tyrosine kinases as therapeutic targets for leukemias: from acute promyelocytic leukemia to chronic myeloid leukemia and beyond.
Hu J; Zhou GB; Wang ZY; Chen SJ; Chen Z
Adv Cancer Res; 2007; 98():191-220. PubMed ID: 17433911
[TBL] [Abstract][Full Text] [Related]
17. [Molecular hemato-oncology and new specific treatment strategies for leukemia].
Martínez-Mancilla M; Zafra-de la Rosa G; Reynoso-Gómez E; Astudillo-de la Vega H; Nambo-Lucio Mde J; Benítez-Bribiesca L; Martínez-Avalos A; Rivera-Luna R; Gariglio P
Gac Med Mex; 2006; 142(2):145-50. PubMed ID: 16711549
[TBL] [Abstract][Full Text] [Related]
18. Treatment of childhood acute myeloid leukemia.
ter Bals E; Kaspers GJ
Expert Rev Anticancer Ther; 2005 Oct; 5(5):917-29. PubMed ID: 16221060
[TBL] [Abstract][Full Text] [Related]
19. Farnesyltransferase inhibitor therapy in acute myelogenous leukemia.
Gotlib J
Curr Hematol Rep; 2005 Jan; 4(1):77-84. PubMed ID: 15610664
[TBL] [Abstract][Full Text] [Related]
20. Targeting signal transduction pathways in colorectal cancer--more than skin deep.
Cohen SJ; Cohen RB; Meropol NJ
J Clin Oncol; 2005 Aug; 23(23):5374-85. PubMed ID: 15998904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
